Mohammad Ghalichi, M.D.
Cardiovascular Disease Physician · Los Angeles, CA
Mohammad Ghalichi, M.D. is a cardiovascular disease physician with a practice address in Los Angeles, California, and NPI 1265697957, issued on Jul 23, 2008. Check the license (California A103682, as entered in NPPES) on the Medical Board of California; the Medicare figures below come from public CMS files.
- Name
- Mohammad Ghalichi
- Credential
- M.D.
- Primary taxonomy
- Cardiovascular Disease Physician 207RC0000X
- License numbers
- A103682 CA
P1311 TX
Self-reported in NPPES; status is on the state search - Practice location
- 8631 W 3RD St Ste 815E, Los Angeles, CA 90048
- Phone
- (424) 340-5222
- Enumerated
- Jul 23, 2008
- Record last updated
- Aug 10, 2021 (not updated in 5 years: call before relying on the address or phone)
- Fax
- (424) 206-4938
- Medicaid IDs
- 323128402 TX
323128403 TX
323128404 TX - Entity
- Type 1 · individual
8 nearest cardiovascular disease physician records → All 2,574 in California → Look up another NPI →
Also registered at 8631 W 3RD St Ste 815E
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Zoe HarengPhysician Assistant1427686229
- Ali Shahi, PAPhysician Assistant1598618324
- Bahman Shamloo, M.DAnesthesiology Physician1871760918
Verify Mohammad Ghalichi in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMedical Board of California
Search for license A103682Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
89% fewer Medicare Part D claims than the average cardiovascular disease physician in 2024
348 Medicare Part D claims for 48 beneficiaries, against an average of 3,078 among the 20,728 providers of this specialty who prescribed in Part D. Brand-name drugs were 45% of claims.
Most prescribed
- Repatha Sureclick105 claims
- Rosuvastatin Calcium54 claims
- Ezetimibe30 claims
- Eliquis21 claims
- Atorvastatin Calcium15 claims
- Amlodipine Besylate14 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $1,064.56
41 payments; by number, the most common kind was food and beverage; the largest payer was Novartis Pharmaceuticals Corporation. The 16,686 providers of this specialty with any payment received $3,819.56 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Mohammad Ghalichi among 2,574 cardiovascular disease physician records in California
Mohammad Ghalichi, M.D. is one of 2,574 cardiovascular disease physician records with a practice address in California. 83% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2008, is newer than 67% of them.
- NPI issued2008 · 67% of these records are older, 28% newer
- In a Medicare fileYes · 83% of these records are
- In the CMS Doctors and Clinicians fileNo · 68% of these records are
- Record last updated2021 · 63% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RC0000X and a California practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Cardiovascular Disease Physician providers in California
There are 2,574 cardiovascular disease physician records in California.
All 2,574 in California → Every provider in Los Angeles → Cardiovascular Disease Physician nationwide →
The 8 cardiovascular disease physician records with the nearest ZIP codes
- Cathleen Bairey Merz, M.D.Los Angeles, CA 900481447238324
- Bojan Cercek, M.D.Los Angeles, CA 900481467413799
- Kirk Chang, M.DLos Angeles, CA 900481215924105
- Yzhar Charuzi, M.DLos Angeles, CA 900481831172840
- Kuang-Yuh Chyu, M.D.Los Angeles, CA 900481437110764
- Robert Davidson, M.DLos Angeles, CA 900481497742381
- Joshua Goldhaber, M.D.West Hollywood, CA 900481750306940
- Martha Gulati, MDLos Angeles, CA 900481275523888
Common questions
What is Mohammad Ghalichi, M.D.'s NPI number?
Mohammad Ghalichi, M.D.'s National Provider Identifier (NPI) is 1265697957, issued on Jul 23, 2008. An NPI identifies a provider in billing; it is not a license.
Where is Mohammad Ghalichi, M.D. located?
The NPPES record lists a practice address at 8631 W 3RD St Ste 815E, Los Angeles, CA, 90048. Phone: (424) 340-5222. Providers update this record themselves, so call before visiting.
How can I verify Mohammad Ghalichi, M.D.'s license?
NPPES lists California license number A103682, as entered by the provider. Search the Medical Board of California at https://www.mbc.ca.gov/License-Verification/default.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Mohammad Ghalichi, M.D. prescribe under Medicare Part D?
In 2024, Mohammad Ghalichi, M.D. had 348 Medicare Part D claims for 48 beneficiaries; the average among cardiovascular disease physician prescribers was 3,078. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.